Industry Partnerships & Commercialization

The Industry Partnerships and Commercialization (IP&C) Office at The Hospital for Sick Children (SickKids) champions the identification, development, and commercialization of cutting-edge health innovations from SickKids researchers, partnering with industry and investors to translate these innovations into impactful healthcare services and products worldwide.

SickKids Innovators

We help researchers navigate commercialization pathways through tailored advice, contract negotiation, intellectual property protection, and more.

Industry Partners

We enable industry partners and investors to tap into the robust innovation ecosystem at SickKids by facilitating research agreements, licensing deals, and start-up creation.

Available Technologies

Our innovation database highlights current technologies from SickKids that are available for licensing, partnership, or other commercialization opportunities.

Transforming SickKids Innovation into Global Health Impact

At IP&C, our team comprises individuals with deep scientific expertise and extensive experience in patenting, licensing, commercial transactions, and startup ventures.

We go beyond traditional tech transfer roles by assisting SickKids Innovators in de-risking their discoveries, maximizing their value, and aligning with investor interests.

Discover how we connect ideas, industry, and investors to create efficient pathways for commercializing research and technology developed at SickKids by watching our video!

Tap Into the Innovation Ecosystem at the SickKids Research Institute

IP&C operates out of the Peter Gilgan Centre for Research and Learning and is a division of the SickKids Research Institute – the largest hospital-based pediatric health institute in Canada.